Gene-based association identifies SPATA13-AS1 as a pharmacogenomic predictor of inhaled short-acting beta-agonist response in multiple population groups.

Padhukasahasram, B

Gene-based association identifies SPATA13-AS1 as a pharmacogenomic predictor of inhaled short-acting beta-agonist response in multiple population groups. [electronic resource] - The pharmacogenomics journal Aug 2014 - 365-71 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1473-1150

10.1038/tpj.2013.49 doi


Administration, Inhalation
Adrenergic beta-Agonists--administration & dosage
Adult
Black or African American
Asthma--drug therapy
Female
Genome-Wide Association Study
Guanine Nucleotide Exchange Factors--genetics
Humans
Male
Middle Aged
Pharmacogenetics
Polymorphism, Single Nucleotide
Population Groups